Skip to content

Evaluation of High tone and Duloxetine on diabetic neuropathy

Comparing the efficacy of Duloxetine with High tone diabetic peripheral neuropathic pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200827048547N1
Enrollment
30
Registered
2020-09-14
Start date
2019-08-28
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy. Other specified diabetes mellitus with diabetic neuropathy, unspecified

Interventions

Intervention 1: Intervention group: Group A In the high tone treatment group, it was done three times a week. In this method, therapeutic electrodes were implanted in the femoral muscles and 230V musc

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Type 1 and 2 diabetes 24-hour mean pain score based on VAS pain visual scale> 4mm

Exclusion criteria

Exclusion criteria: Mood Disorder Disseminated anxiety disorder Avoid substance use A history of less than a year or more than 15 years of diabetes Receive medication to control diabetic polyneuropathy within 2 weeks before starting the study Existence of neuropathy due to another Peripheral vascular disease Pregnant or lactating women History of epilepsy Uncontrolled acute angle-closure glaucoma GFR less than 32 mmol / min Liver disease Heart disease

Design outcomes

Primary

MeasureTime frame
Painful vision scale. Timepoint: During the study and on a weekly basis. Method of measurement: VAS scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnoosh Zakerkish

Ahvaz University of Medical Sciences

zohre.ghafury@gmail.com+98 61 3374 3001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026